Vantage logo

Ash 2020 roundup

Evaluate Vantage's coverage of the virtual Ash 2020 congress.

Vantage logo

Ash 2020 – Crispr gets another boost

Data in three more patients support Crispr and Vertex’s hope of developing a functional cure for beta-thalassaemia and sickle cell disease.

Vantage logo

Finding the next Vertex

Other groups with large disconnects between sellside and investor expectations include Beigene, Alnylam and Acceleron.